» Articles » PMID: 16254429

The Clinical Dementia Rating Sum of Box Score in Mild Dementia

Overview
Publisher Karger
Date 2005 Oct 29
PMID 16254429
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Making an early diagnosis of dementia is becoming increasingly important, but is difficult in practice. The Clinical Dementia Rating (CDR) scale is a widely used dementia staging instrument, yielding a global score and a summated score (sum of box score). This study examines the utility of the CDR sum of box score, rather than the CDR global score, in making a diagnosis of early dementia.

Objective: To determine whether the CDR sum of box score is predictive of an ICD-10 diagnosis of dementia in cases with mild cognitive deficits.

Methods: Clinical data recorded on our Memory Clinic database were examined for all patients seen over a 6-year period. Data were extracted from 276 first visits in which patients had scored 0.5 using the CDR global score. We examined the relationship between CDR sum of box score and consensus diagnosis of dementia using logistic regression.

Results: We found that increased CDR sum of box score was significantly associated with a higher probability of being assigned an ICD-10 diagnosis of dementia (p < 0.001). The odds ratio for the coefficient of CDR sum of box was 2.3 (95% CI 1.7-3.1), indicating that the likelihood of being diagnosed as having dementia increased by a factor of 2.3 for every point increase on the CDR sum of box score.

Conclusion: These findings indicate that the CDR sum of box score provides additional information to the CDR global score in mild cases. The CDR sum of box score is a helpful indicator in making/excluding a diagnosis of dementia in people with mild cognitive deficits.

Citing Articles

Assessing Cognition Remotely: Expanding the Reach of Cognitive Testing for Older Adults at Risk for Dementia in a Randomized Controlled Trial.

Steeves A, Faig K, McGibbon C, Sexton A, Jarrett P Can Geriatr J. 2025; 28(1):87-90.

PMID: 40051592 PMC: 11882207. DOI: 10.5770/cgj.28.790.


A data-driven, multi-domain brain gray matter signature as a powerful biomarker associated with several clinical outcomes.

Fletcher E, Gavett B, Farias S, Widaman K, Whitmer R, Fan A Alzheimers Dement (Amst). 2024; 16(4):e70026.

PMID: 39583650 PMC: 11584916. DOI: 10.1002/dad2.70026.


Impact of shortening time on diagnosis of F-florbetaben PET.

Trinh P, Kim D, Choi K, Kim J EJNMMI Res. 2024; 14(1):114.

PMID: 39570447 PMC: 11582261. DOI: 10.1186/s13550-024-01181-8.


Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions.

Maillard P, Fletcher E, Carmichael O, Schwarz C, Seiler S, DeCarli C Alzheimers Dement. 2024; 20(12):8953-8968.

PMID: 39535353 PMC: 11667517. DOI: 10.1002/alz.14358.


Enlarged perivascular space burden predicts declines in cognitive and functional performance.

Libecap T, Pappas C, Bauer C, Zachariou V, Raslau F, Gold B J Neurol Sci. 2024; 466:123232.

PMID: 39298972 PMC: 11563846. DOI: 10.1016/j.jns.2024.123232.